Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor
Authors:
- Hong-Mei ZhengHZHong-Mei Zheng
- Yujeong JeongYJYujeong Jeong
- Myung-Joo ChoiMCMyung-Joo Choi
- Hyunseung LeeHLHyunseung Lee
- Sang-Won HongSHSang-Won Hong
- Hee-Seung LeeHLHee-Seung Lee
- Mi Kwon SonMSMi Kwon Son
- Soyoung LeeSLSoyoung Lee
- Sungwoo HongSHSungwoo Hong
- Soon-Sun HongSHSoon-Sun Hong
- 1 January 2013
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 328 (1) , 176-187
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- mTOR activates hypoxia-inducible factor-1α and inhibits neuronal apoptosis in the developing rat brain during the early phase after hypoxia–ischemiaNeuroscience Letters, 2012
- Design and Synthesis of Imidazopyridine Analogues as Inhibitors of Phosphoinositide 3-Kinase Signaling and AngiogenesisJournal of Medicinal Chemistry, 2011
- Alpha‐fetoprotein: A new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell linesInternational Journal of Cancer, 2010
- mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPsScience, 2010
- Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2Current Opinion in Cell Biology, 2009
- Molecular therapy for the treatment of hepatocellular carcinomaBritish Journal of Cancer, 2008
- Strategies for the management of hepatocellular carcinomaNature Clinical Practice Oncology, 2007
- Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 2006
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Antimitotic agents. Synthesis of imidazo[4,5-c]pyridin-6-ylcarbamates and imidazo[4,5-b]pyridin-5-ylcarbamatesJournal of Medicinal Chemistry, 1990